SEC Form 4 · accession 0001127602-18-011394
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Herendeen
Officer — EVP and CFO
Period of report
Mar 13, 2018
Accepted (ET)
Mar 13, 2018 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par ValueF1,F2 | Mar 13, 2018 | P | 15,000 | $16.098 | A | 231,492 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price in Column 4 is a weighted average price. The prices actually paid in this transaction range from $16.09 to $16.10 per Common Share.
- F2The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range reported above.